Halo Biosciences
PrivateLast Round
Grant
May 15, 2024
Total Funding Raised
$1.04M
Company Overview
Halo Biosciences is a clinical-stage biopharmaceutical company that develops disease-modifying therapies by targeting the extracellular matrix to treat inflammatory and fibrotic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Halo Biosciences Comparables
Compare Halo Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pliant Therapeutics | 73% | |
| Roivant Sciences | 72% | |
| Mediar Therapeutics | 71% |
Halo Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 15, 2024 | ||||
| Accelerator | Nov 8, 2019 |
Key People
Founding team and executive leadership
Halo Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Heart, Lung, and Blood Institute | Grant |
| QB3 | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 5, 2026
Monthly visitors increased 200% MoM, reaching 1.1K.
- Jan 20, 2026
Monthly visitors increased 1042% MoM, from 31 to 354.
Halo Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Halo Biosciences's valuation, stock price, and market status.
Is Halo Biosciences a public or private company?
Halo Biosciences is a private company.
What is the current stock price of Halo Biosciences?
Halo Biosciences is a private company with no public stock price. No recent secondary market data is available.
How much is Halo Biosciences worth (valuation)?
Valuation information for Halo Biosciences is not publicly available.
Can I buy Halo Biosciences stock?
Halo Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Halo Biosciences's last funding round?
Halo Biosciences's most recent funding round was Grant on May 15, 2024.
Who are the main investors in Halo Biosciences?
Key investors in Halo Biosciences include National Heart, Lung, and Blood Institute, QB3.
Will Halo Biosciences IPO soon?
No public IPO plans have been announced for Halo Biosciences.
How can I track Halo Biosciences secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Halo Biosciences's secondary market activity and sign up for updates.